Cargando…

Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro

Shuang–Huang–Lian injectable powder (SHL)—a classical purified herbal preparation extracted from Scutellaria baicalensis, Lonicera japonica, and Forsythia suspense—has been used against human adenovirus III (HAdV(3)) for many years. The combination herb and its major bioactive compounds, including c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qinhai, Liang, Dedong, Song, Shuai, Yu, Qintian, Shi, Chunyu, Xing, Xuefeng, Luo, Jia-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408685/
https://www.ncbi.nlm.nih.gov/pubmed/28417913
http://dx.doi.org/10.3390/v9040079
_version_ 1783232347597963264
author Ma, Qinhai
Liang, Dedong
Song, Shuai
Yu, Qintian
Shi, Chunyu
Xing, Xuefeng
Luo, Jia-Bo
author_facet Ma, Qinhai
Liang, Dedong
Song, Shuai
Yu, Qintian
Shi, Chunyu
Xing, Xuefeng
Luo, Jia-Bo
author_sort Ma, Qinhai
collection PubMed
description Shuang–Huang–Lian injectable powder (SHL)—a classical purified herbal preparation extracted from Scutellaria baicalensis, Lonicera japonica, and Forsythia suspense—has been used against human adenovirus III (HAdV(3)) for many years. The combination herb and its major bioactive compounds, including chlorogenic acid, baicalin, and forsythia glycosides A, are effective inhibitors of the virus. However, no comprehensive studies are available on the antiviral effects of SHL against HAdV(3). Moreover, it remains unclear whether the mixture of chlorogenic acid, baicalin, and forsythia glycosides A (CBF) has enhanced antiviral activity compared with SHL. Therefore, a comparative study was performed to investigate the combination which is promising for further antiviral drug development. To evaluate their antivirus activity in parallel, the combination ratio and dose of CBF were controlled and consistent with SHL. First, the fingerprint and the ratio of CBF in SHL were determined by high performance liquid chromatography. Then, a plaque reduction assay, reverse transcription polymerase chain reaction (PCR), real-time polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay (ELISA) were used to explore its therapeutic effects on viral infection and replication, respectively. The results showed that SHL and CBF inhibited dose- and time-dependently HAdV(3)-induced plaque formation in A549 and HEp-2 cells. SHL was more effective than CBF when supplemented prior to and after viral inoculation. SHL prevented viral attachment, internalization, and replication at high concentration and decreased viral levels within and out of cells at non-toxic concentrations in both cell types. Moreover, the expression of tumor necrosis factor alpha (TNF)-α, interleukin (IL)-1ß, and IL-6 was lower and the expression of interferon (IFN)-γ was higher in both cell types treated with SHL than with CBF. In conclusion, SHL is much more effective and slightly less toxic than CBF.
format Online
Article
Text
id pubmed-5408685
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-54086852017-05-18 Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro Ma, Qinhai Liang, Dedong Song, Shuai Yu, Qintian Shi, Chunyu Xing, Xuefeng Luo, Jia-Bo Viruses Article Shuang–Huang–Lian injectable powder (SHL)—a classical purified herbal preparation extracted from Scutellaria baicalensis, Lonicera japonica, and Forsythia suspense—has been used against human adenovirus III (HAdV(3)) for many years. The combination herb and its major bioactive compounds, including chlorogenic acid, baicalin, and forsythia glycosides A, are effective inhibitors of the virus. However, no comprehensive studies are available on the antiviral effects of SHL against HAdV(3). Moreover, it remains unclear whether the mixture of chlorogenic acid, baicalin, and forsythia glycosides A (CBF) has enhanced antiviral activity compared with SHL. Therefore, a comparative study was performed to investigate the combination which is promising for further antiviral drug development. To evaluate their antivirus activity in parallel, the combination ratio and dose of CBF were controlled and consistent with SHL. First, the fingerprint and the ratio of CBF in SHL were determined by high performance liquid chromatography. Then, a plaque reduction assay, reverse transcription polymerase chain reaction (PCR), real-time polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay (ELISA) were used to explore its therapeutic effects on viral infection and replication, respectively. The results showed that SHL and CBF inhibited dose- and time-dependently HAdV(3)-induced plaque formation in A549 and HEp-2 cells. SHL was more effective than CBF when supplemented prior to and after viral inoculation. SHL prevented viral attachment, internalization, and replication at high concentration and decreased viral levels within and out of cells at non-toxic concentrations in both cell types. Moreover, the expression of tumor necrosis factor alpha (TNF)-α, interleukin (IL)-1ß, and IL-6 was lower and the expression of interferon (IFN)-γ was higher in both cell types treated with SHL than with CBF. In conclusion, SHL is much more effective and slightly less toxic than CBF. MDPI 2017-04-12 /pmc/articles/PMC5408685/ /pubmed/28417913 http://dx.doi.org/10.3390/v9040079 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ma, Qinhai
Liang, Dedong
Song, Shuai
Yu, Qintian
Shi, Chunyu
Xing, Xuefeng
Luo, Jia-Bo
Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro
title Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro
title_full Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro
title_fullStr Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro
title_full_unstemmed Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro
title_short Comparative Study on the Antivirus Activity of Shuang–Huang–Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro
title_sort comparative study on the antivirus activity of shuang–huang–lian injectable powder and its bioactive compound mixture against human adenovirus iii in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408685/
https://www.ncbi.nlm.nih.gov/pubmed/28417913
http://dx.doi.org/10.3390/v9040079
work_keys_str_mv AT maqinhai comparativestudyontheantivirusactivityofshuanghuanglianinjectablepowderanditsbioactivecompoundmixtureagainsthumanadenovirusiiiinvitro
AT liangdedong comparativestudyontheantivirusactivityofshuanghuanglianinjectablepowderanditsbioactivecompoundmixtureagainsthumanadenovirusiiiinvitro
AT songshuai comparativestudyontheantivirusactivityofshuanghuanglianinjectablepowderanditsbioactivecompoundmixtureagainsthumanadenovirusiiiinvitro
AT yuqintian comparativestudyontheantivirusactivityofshuanghuanglianinjectablepowderanditsbioactivecompoundmixtureagainsthumanadenovirusiiiinvitro
AT shichunyu comparativestudyontheantivirusactivityofshuanghuanglianinjectablepowderanditsbioactivecompoundmixtureagainsthumanadenovirusiiiinvitro
AT xingxuefeng comparativestudyontheantivirusactivityofshuanghuanglianinjectablepowderanditsbioactivecompoundmixtureagainsthumanadenovirusiiiinvitro
AT luojiabo comparativestudyontheantivirusactivityofshuanghuanglianinjectablepowderanditsbioactivecompoundmixtureagainsthumanadenovirusiiiinvitro